• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tiny Optical Sensors Could Eradicate Hospital Bed Sores

    Hypoxia Study Confirms Accuracy of Movano Ring for SpO2 & Heart Rate Monitoring

    Seno Medical's Imagio System Wins Supplemental FDA Approval

    Brad Fluegel Joins NeuroMetrix Board of Directors

    Actuating Implant Design Prevents Scar Tissue Buildup
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    BMP Medical

    Concise Engineering

    Cirtec Medical

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    BMP Medical

    Concise Engineering

    Cirtec Medical

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Second Sight Gets German Approval to Begin Argus II Study

    Trial will measure the improvement of the visual field added by the Argus II for RP patients with tunnel vision.

    Related CONTENT
    • FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    • First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration
    • Second Sight Announces Market Entry into Russia with First Implant of Argus II
    • Wearable System Helps Visually Impaired Users Navigate
    • Ph.D. Student Invents First Synthetic Retina for Visually Impaired
    Business Wire11.03.17
    Second Sight Medical Products Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, has received approval from Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the German competent authority, and a favorable opinion by the applicable ethics committees, to begin a 10-patient study in Germany to implant and evaluate the Argus II Retinal Prosthesis System (Argus II) in better sighted retinitis pigmentosa (RP) patients, or those individuals who have some “tunnel vision.” Tunnel vision is a condition defined by a visual field that is severely constricted.
     
    The clinical study will be conducted with lead principal investigators at three sites in Germany as follows: Universitätsklinikum Aachen with Professor Walter, Städtisches Klinikum Kalrsruhe with Professor Augustin, and Universitätsklinikum Schleswig-Holstein, Universitätsklinikum Lübeck with Professsor Grisanti. The primary endpoint of the study is to measure the improvement of the visual field added by the Argus II for RP patients with tunnel vision. A secondary endpoint will be to evaluate how well those treated with the Argus II integrate the system into their daily lives.
     
    “This is an important study and part of our strategy to evaluate the Argus II in better sighted individuals. We are excited by the opportunity to potentially improve the functional vision of additional blind individuals suffering from RP and look forward to initiating enrollment by the end of this year. If successful, the targeted population could increase the potential market for the Argus II by two to three times its current size,” stated Will McGuire, president and CEO of Second Sight.
     
    Professor Walter, Universitätsklinikum Aachen, commented, “This study has the potential to change the management of patients with RP and, if successful, greatly expand the patient population who can benefit from this treatment, and for whom the Argus II could be a solution.”
     
    Second Sight's Argus II System provides electrical stimulation that bypasses the defunct retinal cells and stimulates remaining viable cells inducing visual perception in individuals with severe to profound Retinitis Pigmentosa. The Argus II works by converting images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses, which are transmitted wirelessly to an array of electrodes implanted on the surface of the retina. These pulses stimulate the retina's remaining cells, intending to result in the perception of patterns of light in the brain. The patient must learn to interpret these visual patterns, having the potential to regain some visual function. The Argus II was the first artificial retina to receive widespread commercial approval, and is offered at approved centers in Canada, France, Germany, Italy, Russia, Saudi Arabia, South Korea, Spain, Taiwan, Turkey, the United Kingdom, and the United States.
     
    Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and now manufactures and markets, the Argus II Retinal Prosthesis System. Enrollment has been completed in a feasibility trial to test the safety and utility of the Argus II in individuals with dry age-related macular degeneration. Second Sight is also developing the Orion Visual Cortical Prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. The company's U.S. headquarters is in Sylmar, Calif., and its European headquarters is in Lausanne, Switzerland.
    Related Searches
    • safety
    • patient
    • argus ii retinal prosthesis
    • brain
    Suggested For You
    FDA Approves Second Sight FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration
    Second Sight Announces Market Entry into Russia with First Implant of Argus II Second Sight Announces Market Entry into Russia with First Implant of Argus II
    Wearable System Helps Visually Impaired Users Navigate Wearable System Helps Visually Impaired Users Navigate
    Ph.D. Student Invents First Synthetic Retina for Visually Impaired Ph.D. Student Invents First Synthetic Retina for Visually Impaired
    Competition Seeks Development of Human Eye Tissue in a Dish Competition Seeks Development of Human Eye Tissue in a Dish

    Related Breaking News

    • FDA Approves Second Sight

      FDA Approves Second Sight's Argus 2s Retinal Prosthesis

      Features significantly more processing power.
      Sam Brusco, Associate Editor 03.08.21

    • First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration

      First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration

      Telescope implant for end-stage macular degeneration is FDA approved and available to patients 65 years and older.
      Business Wire 10.13.17

    • Second Sight Announces Market Entry into Russia with First Implant of Argus II

      Second Sight Announces Market Entry into Russia with First Implant of Argus II

      Company marks continued global expansion of Argus II for individuals blinded by retinitis pigmentosa.
      Business Wire 08.10.17


    • Digital Health
      Wearable System Helps Visually Impaired Users Navigate

      Wearable System Helps Visually Impaired Users Navigate

      Device provides information from a 3D camera, via vibrating motors, and a Braille interface.
      Larry Hardesty, MIT News Office

    • Materials | Surgical
      Ph.D. Student Invents First Synthetic Retina for Visually Impaired

      Ph.D. Student Invents First Synthetic Retina for Visually Impaired

      Could revolutionize the bionic implant industry and the development of new, less invasive technologies.
      University of Oxford 05.05.17

    Loading, Please Wait..

    Trending
    • U.K. Strengthens Medical Device Regulations
    • FDA OKs Bodyport's Cardiac Scale, A Noninvasive Biomarker Platform
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    Breaking News
    • Tiny Optical Sensors Could Eradicate Hospital Bed Sores
    • Hypoxia Study Confirms Accuracy of Movano Ring for SpO2 & Heart Rate Monitoring
    • Seno Medical's Imagio System Wins Supplemental FDA Approval
    • Brad Fluegel Joins NeuroMetrix Board of Directors
    • Actuating Implant Design Prevents Scar Tissue Buildup
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Protein Ingredient Formulated for Chronic Kidney Disease Patients
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Urges the House to Pass the Inflation Reduction Act
    The ChemQuest Technology Institute Enters Agreement with Universal Matter
    Sherwin-Williams’ TERRA: Embracing Community & Connection in 2023
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Tiny Optical Sensors Could Eradicate Hospital Bed Sores
    Hypoxia Study Confirms Accuracy of Movano Ring for SpO2 & Heart Rate Monitoring
    Seno Medical's Imagio System Wins Supplemental FDA Approval
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Catalent to Acquire Metrics Contract Services for $475M
    Sartorius Stedim Biotech Agrees to Acquire Albumedix
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Luster Products Unveils Comfort Oil Scalp Serum
    Anomatic & Novelis Introduce Eco-Friendly Alloy
    Happi

    Latest Breaking News From Happi

    TBH Kids Enters Retail Market with Exclusive Partnership with HEB Stores
    Blushington Expands with New Services and Manhattan Flagship Launch
    Makeup in New York Returns to the Javits Center on Sept. 14-15
    Ink World

    Latest Breaking News From Ink World

    INX to Highlight New Products at Labelexpo Americas
    Sonoco Names Aditya Gandhito Company’s First Chief Accounting Officer
    Quinacridone Pigments Market Size Projected to Reach $539 Million by 2030: Straits
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    APR issues report on state of US recycling
    Durst details Labelexpo Americas product lineup
    Heidelberg USA-Gallus opens new Screeny Demo Room in Pennsylvania
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Vapor Fresh Upgrades Plant-Based Gym Wipe Canisters
    Suominen Releases Half-Year Financial Report
    Essity Switches to Recyclable Packs for Feminine Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    Zavation Shares Results from In-Vitro and In-Vivo Research Study for its Labyrinth Technology
    Cortland Biomedical Adds Suite of Post-Processing Services & Technologies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Stratasys Signs Agreement to Acquire Covestro’s Additive Manufacturing Materials Business
    The Future of Electronics RESHAPED Event Reports High Demand
    SEMI Applauds President Biden’s Signing of CHIPS and Science Act of 2022

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login